s Lipitor, AstraZeneca’s Plc’s Crestor, and rival drugs to lower cholesterol also boost diabetes rates by about 9 percent, according to a study that quantified a complication that doctors only recently discovered. Manufacturers of pacemakers, drug …

Link:
Today’s Globe – Boston Globe